title: Conversion to the COBAS AmpliPrep/COBAS TaqMan CMV Test for management of CMV disease in transplant recipients.
abstract: Testing of clinical plasma specimens by the COBAS AmpliPrep/COBAS TaqMan CMV Test (CAP/CTM CMV), COBAS AMPLICOR CMV MONITOR Test (CAM CMV), and a laboratory-developed assay using analyte-specific reagents (LC CMV) demonstrated substantial result bias for CAP/CTM CMV versus CAM CMV (r = 0.436) and CAP/CTM CMV versus LC CMV (r = 0.773).
authors: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
authors: Bobbi S
authors: BS
authors: Pritt
authors: Jeffrey J
authors: JJ
authors: Germer
authors: Eric
authors: E
authors: Gomez-Urena
authors: Callie J
authors: CJ
authors: Bishop
authors: Jayawant N
authors: JN
authors: Mandrekar
authors: Cole L
authors: CL
authors: Irish
authors: Joseph D C
authors: JD
authors: Yao
mesh_terms: D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000821:virology; D006801:Humans; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D060888:Real-Time Polymerase Chain Reaction / Q000379:methods*; D014180:Transplantation; D019562:Viral Load / Q000379:methods*; D014773:Virology / Q000379:methods*